These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 24782863)

  • 1. Organizing MHC Class II Presentation.
    Fooksman DR
    Front Immunol; 2014; 5():158. PubMed ID: 24782863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen presentation by mouse CD4+ T cells involving acquired MHC class II:peptide complexes: another mechanism to limit clonal expansion?
    Tsang JY; Chai JG; Lechler R
    Blood; 2003 Apr; 101(7):2704-10. PubMed ID: 12433692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Major histocompatibility complex (MHC) class II-peptide complexes arrive at the plasma membrane in cholesterol-rich microclusters.
    Bosch B; Heipertz EL; Drake JR; Roche PA
    J Biol Chem; 2013 May; 288(19):13236-42. PubMed ID: 23532855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen-B Cell Receptor Complexes Associate with Intracellular major histocompatibility complex (MHC) Class II Molecules.
    Barroso M; Tucker H; Drake L; Nichol K; Drake JR
    J Biol Chem; 2015 Nov; 290(45):27101-27112. PubMed ID: 26400081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fish oil disrupts MHC class II lateral organization on the B-cell side of the immunological synapse independent of B-T cell adhesion.
    Rockett BD; Melton M; Harris M; Bridges LC; Shaikh SR
    J Nutr Biochem; 2013 Nov; 24(11):1810-6. PubMed ID: 23791516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4 and CD8 accessory molecules function through interactions with major histocompatibility complex molecules which are not directly associated with the T cell receptor-antigen complex.
    Lustgarten J; Waks T; Eshhar Z
    Eur J Immunol; 1991 Oct; 21(10):2507-15. PubMed ID: 1915555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of CD4 T cell function by soluble MHC II-peptide chimeras.
    Casares S; Bona CA; Brumeanu TD
    Int Rev Immunol; 2001 Oct; 20(5):547-73. PubMed ID: 11890612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparan sulfates targeting increases MHC class I- and MHC class II-restricted antigen presentation and CD8(+) T-cell response.
    Knittel D; Gadzinski A; Hua S; Denizeau J; Savatier A; de la Rochère P; Boulain JC; Amigorena S; Piaggio E; Sedlik C; Léonetti M
    Vaccine; 2016 Jun; 34(27):3093-3101. PubMed ID: 27154391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of bispecific heteroconjugated antibodies (anti-T cell antigen receptor x anti-MHC class II) to study activation of T cells with a full length or truncated antigen receptor zeta-chain.
    Wu S; Yang Y; Sadegh-Nasseri S; Ashwell JD
    J Immunol; 1993 Mar; 150(6):2211-21. PubMed ID: 8450208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloned T cells internalize peptide from bound complexes of peptide and purified class II major histocompatibility complex antigen.
    Nag B; Deshpande SV; Sharma SD; Clark BR
    J Biol Chem; 1993 Jul; 268(19):14360-6. PubMed ID: 7686154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation.
    Dang LH; Lien LL; Benacerraf B; Rock KL
    J Immunol; 1993 May; 150(10):4206-17. PubMed ID: 8482833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costimulation and endogenous MHC ligands contribute to T cell recognition.
    Wülfing C; Sumen C; Sjaastad MD; Wu LC; Dustin ML; Davis MM
    Nat Immunol; 2002 Jan; 3(1):42-7. PubMed ID: 11731799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular recognition of antigen involves lattice formation between CD4, MHC class II and TCR molecules.
    Sakihama T; Smolyar A; Reinherz EL
    Immunol Today; 1995 Dec; 16(12):581-7. PubMed ID: 8579751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell antigen receptor recognition of antigen-presenting molecules.
    Rossjohn J; Gras S; Miles JJ; Turner SJ; Godfrey DI; McCluskey J
    Annu Rev Immunol; 2015; 33():169-200. PubMed ID: 25493333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MHC class II-expressing hepatocytes function as antigen-presenting cells and activate specific CD4 T lymphocyutes.
    Herkel J; Jagemann B; Wiegard C; Lazaro JF; Lueth S; Kanzler S; Blessing M; Schmitt E; Lohse AW
    Hepatology; 2003 May; 37(5):1079-85. PubMed ID: 12717388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presentation of acquired peptide-MHC class II ligands by CD4+ regulatory T cells or helper cells differentially regulates antigen-specific CD4+ T cell response.
    Zhou G; Ding ZC; Fu J; Levitsky HI
    J Immunol; 2011 Feb; 186(4):2148-55. PubMed ID: 21242518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clustering of Major Histocompatibility Complex-Class I Molecules in Healthy and Cancer Colon Cells Revealed from Their Nanomechanical Properties.
    Moretti M; La Rocca R; Perrone Donnorso M; Torre B; Canale C; Malerba M; Das G; Sottile R; Garofalo C; Achour A; Kärre K; Carbone E; Di Fabrizio E
    ACS Nano; 2021 Apr; 15(4):7500-7512. PubMed ID: 33749234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thirty-six views of T-cell recognition.
    Krummel M; Wülfing C; Sumen C; Davis MM
    Philos Trans R Soc Lond B Biol Sci; 2000 Aug; 355(1400):1071-6. PubMed ID: 11186308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MHC class II-dependent peptide antigen versus superantigen presentation to T cells.
    Shoukry NH; Lavoie PM; Thibodeau J; D'Souza S; Sekaly RP
    Hum Immunol; 1997 May; 54(2):194-201. PubMed ID: 9297538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4-Ia interactions can occur in the absence of T-cell receptor/antigen-Ia recognition.
    Andris F; Leo O; Van Mechelen M; Urbain J; Slaoui M
    Immunology; 1989 Sep; 68(1):1-6. PubMed ID: 2530152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.